Singapore, Jan. 2 -- South Korea-based KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global business expansion by strengthening its high-value tissue-based product portfolio to target the rapidly growing global bone graft market.

The global bone graft market is a high-growth medical device sector, driven by steadily increasing usage in orthopedic surgery, spinal procedures, and dental implants. The market is projected to reach approximately $6.66 billionby 2032. In particular, human tissue-based products continue to gain market preference and profitability due to their limited supply and consistently strong demand.

KLMBio is implementing a global marketing strategy under the slogan "Korea...